Fundamentals data is not available for this company.
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-25 | 44.25 | (489.84) | (741.38)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-26 | 107.81 | (489.87) | (736.25)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-27 | 271.65 | (367.51) | (524.29)¢ | n/a | n/a | n/a | n/a | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
Agios Pharmaceuticals to sell cancer portfolio t... | 21-Dec-2020 | ShareCast |
Currency | US Dollars |
Share Price | $ 37.70 |
Change Today | $ -0.25 |
% Change | -0.66 % |
52 Week High | $61.64 |
52 Week Low | $25.90 |
Volume | 1,358,929 |
Shares Issued | 58.68m |
Market Cap | $2,212.26m |
RiskGrade | 304 |
Strong Buy | 1 |
Buy | 3 |
Neutral | 4 |
Sell | 0 |
Strong Sell | 0 |
Total | 8 |
Time | Volume / Share Price |
16:00 | 882,414 @ $37.70 |
15:59 | 100 @ $37.68 |
15:59 | 771 @ $37.69 |
15:59 | 265 @ $37.70 |
15:59 | 100 @ $37.69 |
You are here: research